We’re proud to announce that Bova Group has achieved Silver Level Accreditation from Investors in the Environment (iiE) with an overall score of 85%!
Auckland, New Zealand, 13 August 2025 — CompoundLabs, a leading New Zealand compounding pharmacy, is pleased to announce its official partnership with Bova Group, a global leader in veterinary pharmaceutical compounding. This alliance brings CompoundLabs into a trusted international network of veterinary compounding partners, enabling access to innovative, clinically validated formulations for veterinarians across New Zealand.
Bova welcomes Andrew Rowe as Chief Operating Officer to lead global expansion, innovation, and veterinary pharmaceutical excellence. Learn more about this exciting move.
[news] Bova UK is proud to announce its partnership with Vet Sustain, a pioneering organisation committed to supporting sustainability across the veterinary professions.
We’re excited to share an update on Bova Group’s sustainability journey. As a pharmaceutical manufacturer serving the veterinary industry, we are committed to embedding sustainability into everything we do. Together with the support of our parent company Nextmune and Vimian, we’ve made significant progress, laying a strong foundation for long-term environmental responsibility across our sites in London and Sydney.
[news] Our website now has a B rating, making it cleaner than 70% of global websites.
[News] Bova at BVNA Congress 2024. Bova UK has been awarded Runner Up for the BVNA Exhibitors Sustainability Award 2024!
[News] Bova at BEVA Congress 2024: A Memorable Event for Equine Vets Worldwide. Bova’s Role at BEVA 2024: A Sponsor and Award Winner!